North Chicago, Illinois, United States Related Funds
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Oisin Biotechnologies | $15M | 24 Jul 2024 | Seattle, Washington, United States | ||
DISCO Pharmaceuticals | $23M | 16 Jan 2024 | Cologne, Nordrhein-Westfalen, Germany | ||
Mozart Therapeutics | $25M | 07 Jun 2023 | - | ||
Jnana | $107M | 15 Nov 2022 | Boston, Massachusetts, United States | ||
AmbAgon Therapeutics | $85M | 06 Jan 2022 | San Francisco, California, United States | ||
Nitrome Biosciences | $7M | 02 Nov 2021 | Jackson, Mississippi, United States | ||
Quanta Therapeutics | $60M | 26 Oct 2021 | San Francisco, California, United States | ||
Jnana | $50M | 18 Aug 2021 | Boston, Massachusetts, United States | ||
Starday Foods | $4M | 17 Aug 2021 | - |
– Jnana Therapeutics, a biotechnology company utilizing its next generation chemoproteomic platform to target SLC transporters and other well-validated but hard-to-drug targets, announced the closing of a $50m Series B financing.
– The financing was led by RA Capital Management, and included all existing investors, including Polaris Partners, Versant Ventures, Avalon Ventures, AbbVie Ventures and Pfizer Ventures.
– Proceeds from this financing will enable Jnana to progress its lead program for the treatment of phenylketonuria (PKU) into clinical development, while advancing a pipeline of additional programs and continuing to invest in its innovative and validated RAPID platform for the discovery of small molecule therapeutics for hard-to-drug targets.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Oisin Biotechnologies | $15M | 24 Jul 2024 | Seattle, Washington, United States | ||
DISCO Pharmaceuticals | $23M | 16 Jan 2024 | Cologne, Nordrhein-Westfalen, Germany | ||
Mozart Therapeutics | $25M | 07 Jun 2023 | - | ||
Jnana | $107M | 15 Nov 2022 | Boston, Massachusetts, United States | ||
AmbAgon Therapeutics | $85M | 06 Jan 2022 | San Francisco, California, United States | ||
Nitrome Biosciences | $7M | 02 Nov 2021 | Jackson, Mississippi, United States | ||
Quanta Therapeutics | $60M | 26 Oct 2021 | San Francisco, California, United States | ||
Jnana | $50M | 18 Aug 2021 | Boston, Massachusetts, United States | ||
Starday Foods | $4M | 17 Aug 2021 | - |
